ABSTRACT Experimental studies have demonstrated that long-non-coding RNAs (lncRNAs) are closely related to human disease. However, due to the complexity of diseases and high costs of bio-experiments, associations between diseases and lncRNAs are still unclear. Hence, it is essential to establish effective computational models to predict the potential relationships between diseases and lncRNAs. In this paper, different from traditional prediction models based on random walk with restart (RWR), a novel prediction model based on internal inclined random walk with restart (IIRWR) has been established to infer potential lncRNA-disease associations and compared to the state-of-the-art RWR-based prediction models. One major novelty of our IIRWR-based prediction model is the introduction of the concept of disease clique, which makes the process of the random walk to possess an internal tendency. The other major novelty of our model lies in the addition of the weights of disease linkages to the traveling network, which guarantees our model can achieve excellent prediction performance while the number of known lncRNA-disease associations is limited. The simulation results show that our model can achieve reliable AUCs of 0.8080, 0.8363, and 0.8745 under the frameworks of five-fold cross-validation (CV), ten-fold CV, and leave-one-out cross validation (LOOCV), respectively. Moreover, in case studies of cervical cancer and leukemia, the experimental results show that eight and ten out of the top ten predicted lncRNAs can be confirmed by related literature, which demonstrates that our method is effective in predicting novel diseases associated lncRNAs.
I. INTRODUCTION
Accumulating evidence suggests that lncRNAs play critical roles in lots of biological processes such as epigenetic regulation, cell cycle regulation, cell differentiation, transcriptional regulation, and so on [1] - [5] . With more and more lncRNAs being identified by newly developed sequencing technologies, their functions especially their contributions to various diseases have received much attention recently. More and more biological experiments have shown that mutations and dysregulations of lncRNA are associated with diseases [6] - [8] , such as leukemia [9] , [10] , cardiovascular diseases [11] , Alzheimer's disease [12] and various kinds of cancers [13] . Therefore, effectively identifying the The associate editor coordinating the review of this manuscript and approving it for publication was Chee Keong Kwoh. association between disease and lncRNA cannot only help us understand the molecular mechanism of disease but also provide biomarkers for disease treatment and find drug target. Many lncRNA-related databases including LncRNADisease [14] , NRED [15] , lncRNAdb [16] and NONCODE [17] have been established successively. However, since traditional bio-experiments in testing the relationships between lncRNAs and diseases are costly and time-consuming, the numbers of known lncRNA-disease associations in these databases are still small [18] - [20] . Hence, it is necessary to develop high-throughput computational models to discover potential lncRNA-disease associations. Various computational models have been proposed for this purpose.
According to their implementation strategy, these methods can be roughly classified into three categories to predict novel lncRNA-disease associations [6] . The first category is to build a machine learning model that predicts potential lncRNA-Disease association based on known lncRNAdisease associations. For instance, Yu and Wang et al. develop a Naive Bayesian Classifier to predict lncRNAdisease associations [21] , which builds two global networks by integrating multiple biological information to predict potential lncRNA-disease associations. However, this kind of supervised classifier model needs negative sample information, which is usually unavailable. So they randomly selected unlabeled lncRNA-disease pairs as negative samples, which would affect the prediction performance. In 2013, Chen et al. establish a model of Laplacian Regularized Least Squares for LncRNA-Disease Association (LRLSLDA) to predict potential lncRNA-disease association base on a semisupervised learning framework [22] . This model does not require negative sample information, and meanwhile significantly improves the performance of previous predictions. However, there are also some limitations, for example, how to choose the optimal parameters have not been solved.
The second category are to integrate known lncRNAdisease association network, disease similar network, lncRNA similar network to establish a heterogeneous network, and implement propagation algorithm. In 2014, Sun et al. propose a prediction model named RWRlncD by adopting random walk with restart (RWR) in the lncRNA functional similarity network [23] . As a matter of fact, the random walk algorithm has been widely used in bioinformatics and other fields, and has achieved good performance. For example, Yang and Li et al. develop a model called RWPCN (Random Walker on Protein Complex Network) for predicting and prioritizing disease genes [24] . In the same year, Yang et al. establish coding-non-coding gene-disease bipartite network by integrating known disease genes with lncRNA-disease associations [25] , and implement propagation algorithms on this bipartite network to predict potential lncRNA-disease associations. Although this model achieved good predictive performance, there is some limitation such as the lack of lncRNA function annotation would have an influence on its performance.
Due to the confirmed lncRNA-disease associations are still limited, some researchers began to predict potential lncRNAdisease associations by other means, rather than the above two categories method based on known lncRNA-disease association pairs. For example, in 2014, Liu et al. established the first computational model that does not rely on known lncRNA-disease association [26] , it integrates disease genes and the relationship between genes and lncRNA, successfully avoided the limitations of using limited lncRNA-disease correlation samples, however, this model can not be applied to lncRNA that without related gene records.
In this paper, a novel Internal Inclined Random Walk with Restart (IIRWR) was proposed to predict potential lncRNAdisease associations by integrating known lncRNA-disease associations, disease semantic similarity, disease weight and Gaussian interaction profile kernel similarity for lncRNAs. Different from the traditional RWR method, IIRWR in the addition of the weights of disease linkages to the traveling network, solved some limitations of the traditional RWR method such as aimlessness, ensuring that our models get better predictive performance (MATLAB code can be downloaded at https://github.com/xiaoyubin123/code.git). In order to better estimate the prediction performance of our newly proposed IIRWR-based model, several methods including 5-fold Cross Validation (5-fold CV), 10-fold Cross Validation (10-fold CV) and Leave-One-Out Cross Validation (LOOCV) have been implemented. As a result, our IIRWR-based model can achieve reliable AUCs of 0.8080, 0.8363, 0.8745 in the 5-fold CV, 10-fold CV and LOOCV, respectively, outperforming those of several state-of-the-art traditional RWR-based models. Moreover, we also validated novel lncRNA-disease associations predicted by our method by literature mining.
II. MATERIALS AND METHODS

A. CONSTRUCTION OF THE ADJACENCY MATRIX OF KNOWN LNCRNA-DISEASE ASSOCIATIONS
In this paper, we downloaded lncRNA-disease associations from the latest version of the LncRNADisease database (http://www.cuilab.cn/lncrnadisease) [14] . After removing non-human data and repeated associations supported by multiples evidences, we finally got 1695 unique experimentally verified human lncRNA-disease associations (see Supplementary material 1), which including 828 unique lncRNAs and 314 unique diseases. The data can be expressed as an 828 × 314 lncRNA-disease association adjacency matrix A, in which A(i, j) =, if and only if there is a known association between lncRNA l i and disease d j , and A(i, j) = 0 otherwise. In addition, we defined N L = 828 and N D = 314, thus, the newly obtained adjacency matrix A is of dimension N L × N D .
B. CONSTRUCTION OF THE DISEASE SEMANTIC SIMILARITY MATRIX
For each of the 314 diseases, we further downloaded its corresponding MESH descriptor from the National Library of Medicine (http://www.nlm.nih.gov) [27] , which categorizes and provides semantic information for various diseases. In the light of previous knowledge, relationships between different diseases can be illustrated as a structure of Directed Acyclic Graph (DAG) [27] , [28] . For example, a disease d can be described as
is a node set consist of d itself and its ancestor nodes, while E(d) is the set of directed edges from parents to child nodes. Therefore, for a disease d and one of its ancestor nodes t in D(d), we can define the contribution of disease t to the semantic value of disease d as follow:
is the semantic contribution factor with value between 0 and 1, according to experimental results done by VOLUME 7, 2019 FIGURE 1. The DAG corresponding to the digestive system neoplasms.
predecessors [27] , it is better to set to 0.5. Hence, by combining contributions from all disease terms in DAG(d), we can define the semantic value of d as follow:
According to formula (1) and formula (2), the calculation of the semantic value of Digestive-System Neoplasms D (DSN) was shown in Fig. 1 , There is D(DSN) = 1 (the contribution of Digestive System Neoplasm) + 0.5 (the contribution of Neoplasms by site) + 0.5 (the contribution of Digestive system Disease) + 0.5*0.5 (the contribution of Neoplasms) = 2.25.
Moreover, based on the concept of DAG, it is reasonable to assume that two diseases with more common ancestor nodes will have higher semantic similarity, the disease semantic similarity (DSS ) between disease d i and disease d j can be calculated as follow:
Therefore, an ND × ND dimensional DSS matrix can be constructed(see Supplementary material 2).
C. CONSTRUCTION OF THE GAUSSIAN INTERACTION PROFILE KERNEL SIMILARITY MATRIX FOR LNCRNAS
For any two given lncRNAs l i and l j , the Gaussian interaction profile kernel similarity (KL) between them can be defined as follows [29] :
IP(l i ) and IP(l j ) denote the i th and j th column in the adjacency matrix A (i, j) separately, γ l control kernel bandwidth base on normalizing the new bandwidth parameter γ l , the best choice of γ l is 1 depend on previous data [22] . Combining formula (4) and formula (5) , an N L × N L dimensional Gaussian interaction profile kernel similarity matrix KL is established.
D. CONSTRUCTION OF THE IIRWR-BASED PREDICTION MODEL
As illustrated in Fig. 2 , the IIRWR-based prediction model consists of three major steps.
Step 1: Constructing the roaming network (lncRNAs network) based on diseases similarity and lncRNAs similarity.
Step 2: Implementing random walk on the newly constructed roaming network.
Step 3: Ranking candidate lncRNAs after obtaining stable random walk probability.
1) STEP 1: CONSTRUCTION OF THE ROAMING NETWORK AND INITIAL PROBABILITY
Step 1.1 (Revision the Disease Semantic Similarity Matrix: Although a DSS matrix can be constructed through formula (3), the matrix is very sparse. Moreover, for any disease d i , it is obvious that elements with a value not equal to zero in the i th row of DSS matrix represent all collected diseases that are related to d i . lncRNA with more associations to disease clique will have greater relevance to the target disease. Thus, we defined the set of elements with the value not equal to zero in the i th row of DSS matrix as the Disease Clique of disease d i . Thereafter, for any two diseases d i and d j , the similarity between them can be re-calculated as follows:
Here, α is the penalty factor with a value between 0 and 1, DS(i) denotes the set consisting of the nonzero elements in the i th row of DSS. Along with rectification by formula (6) and formula (7), the problem of the sparsity of the DSS matrix is solved efficiently.
Step 
Here, DL(i) represents a set of diseases that have known associations with l i , SDW(j) denotes the j th row of the matrix SDW. The calculation process of the DW matrix is illustrated in detail. As showed in Fig. 3 (1) , there are three diseases d 3 , d 4 and d 5 related with lncRNA l 1 , then we can obtain that RDSS (3,1) = 0.68, RDSS (4,1) = 0.9, RDSS (5,1) = 0.7 through Fig. 3 (2) and (3) . Therefore, SDW (1, 1) = RDSS(3,1) + RDSS (4,1) + RDSS (5,1) = 0.68 + 0.9 + 0.7 = 2.28. Finally, DW(1,1) = 1 according to formula (8) ,  Fig. 3 (4) . Step 1.3 (Construction of the Roaming Network): For any given disease d m , as a walker, it can move from the current node to the next node according to a transition probability matrix and obtain the migration probability vector of the next hop node simultaneously. Therefore, based on formula (4) and formula (8) , for any two given lncRNAs l i and l j , an N L × N L dimensional transition probability matrix TPM can be structured as follows:
Based on the matrix TPM, a roaming network can be obtained easily, in which, the node-set consists of N L = 828 kinds of lncRNAs. For any two given lncRNA nodes l i and l j in the roaming network, there is an edge between them when TPM (i, j) > 0.
Additionally, let the disease d m be a walker, then for each lncRNA l i (i∈[1, N L ]), we can structure a N L dimensional initial probability vector IPM 0 for d m as follows: 
3) STEP 3: OBTAIN THE RANKS OF CANDIDATE LNCRNAS
For any given disease node d m , while it walks in the roaming network, all lncRNAs have known associations with d m will be regarded as seed lncRNAs, while other lncRNAs without associations with d m will be considered as the candidate lncRNAs. According to formula (14) , it is easy to deduce that the probability vector IPM t obtained by d m will be stable in final as long as t is big enough. Additionally, in view of time efficiency and accuracy requirement, IPM t will be considered stable if the difference between IPM t and IPM t+1 is less than 10 −10 . So far, we can get the ranking for all lncRNAs based on IPM t , for any given lncRNA l i , the higher the ranking the more probability it would be associated with the disease walker d m .
III. RESULTS
A. PERFORMANCE EVALUATION
In order to assess the prediction performance of IIRWR, the framework of LOOCV was firstly implemented based on our previously obtained 1695 known lncRNA-disease associations. During the experiment, for a given disease d, each lncRNA has known association with disease d was left out as a test sample in turn, and all other lncRNAs have associations with disease d was retained as seed lncRNAs or training samples for our model learning. Test samples and those lncRNAs have no associations with disease d were considered as candidate lncRNAs. Thus the ranking of the left-out test sample relative to candidate samples could be evaluated. If the ranking of the test sample is greater than the given threshold, then it would be regarded as a successful prediction, otherwise, it is an unsuccessful prediction. Moreover, upon different given thresholds, their corresponding true positive rates (TPR, sensitivity) and false positive rate (FPR, 1-specificity) could be figured out, in which sensitivity denotes the percentage of test samples with ranking higher than the corresponding threshold, while specificity represents the percentage of test samples that rank below the corresponding threshold. Hence, the Receiver-Operating Characteristics (ROC) curve can be drawn through plotting TPR versus FPR at different thresholds, and the area below ROC curve (AUC) could be applied to evaluate the prediction performance of our prediction model IIRWR. In general, the AUC value of 1 represents a perfect prediction while the AUC value of 0.5 means a random guess. However, in the experimental process of LOOCV, there would be a situation that the left-out lncRNA is the only lncRNA has known association with a specific disease, which would lead to both the initial probability vector IPM 0 turning to be a zero vector and some points in the ROC curve focus on the location of FPR = 0.5. In order to ensure the fairness of our forecasted results, we have randomly set an initial vector in this kind of situation. Through simulation, we first compared IIRWR with three state-of-the-art lncRNA-disease association prediction models KATZLDA [30] , LRLSLDA [22] and PMFILDA [31] in the framework of LOOCV. The comparison results were shown in Fig. 4 . IIRWR achieves a reliable AUC of 0.8745, which is higher than that of 0.8257 acquired by KATZLDA, the AUC of 0.7003 obtained from LRLSLDA and the AUC of 0.8346 from PMFILDA. Besides, in the validation experiment, it took about 3 seconds for our IIRWR model to validate a lncRNA-disease association, while it cost more than 10 seconds for both KATZLDA and LRLSLDA.
Next, the performance of our IIRWR model was further compared with several others state-of-the-art lncRNA-disease association prediction models such as LRLSLDA [22] , RWRLNCD [23] and NRWRH [32] and in the framework of LOOCV. Considering that different data versions may lead to different prediction performance, we downloaded the same dataset adopted by RWRLNCD, NRWRH and LRLSLDA from the 2012 version of the lncRNADisease database, which consists of 293 known lncRNA-disease associations including 167 different diseases and 118 various lncRNAs. The comparison results were listed in Table. 1. IIRWR achieves reliable AUC of 0.6796, which far outweighs the AUC of 0.5024 from RWRLNCD, and also higher than the AUC of 0.6363 in NRWRH and 0.6585 achieved by LRLSDA as well. Then, IIRWR was compared with the recently proposed two state-of-the-art computational models such as BRWLDA [33] and SIM-CLDA [34] in the framework of LOOCV. Consistent with the above comparison, we downloaded the same database adopted by BRWLDA and SIMCLDA from the 2014 version of lncRNADisease database,which consists of 319 known lncRNA-disease associations including 169 different diseases and 131 various lncRNAs. As shown in Fig. 5 , we can see that IIRWR achieves a reliable AUC of 0.8464,which is significantly higher than AUCs of others (0.7874 from BRWLDA and 0.7741 from SIMCLDA).
In addition, by comparing Table. 1, Fig. 4 and Fig. 5 , it is easy to find that the AUC achieved by IIRWR based on the 2012 version of the lncRNADisease database is not as good as that based on the 2014 version, Even far below the 2017 version. This difference is owing to the known lncRNA-disease associations in the dataset of 2012 version is sparse than in the dataset of 2014 version and 2017 version. Therefore, for the purpose of further assess the prediction performance of IIRWR, frameworks of K-fold Cross Validation including 5-fold Cross Validation (5-fold CV) and 10-fold Cross Validation (10-fold CV) were applied. In the framework of K-fold Cross Validation, all these known lncRNA-disease associations were equally divided into K distinct groups, each group was ruled out as a test group in turn, while others were retained as training groups. Fig. 6 and Fig. 7 shows that IIRWR can achieve reliable AUC of 
B. SENSITIVITY ANALYSIS OF PARAMETERS
According to above descriptions, there are two major parameters in our prediction model IIRWR, one is the parameter α in formula (6) , and the other is the parameter r in the formula (13) . In this section, the effects of both parameters to the performance of our prediction model were estimated. For testing the effect of the parameter α, a series of AUCs in the framework of LOOCV with α varying from 0 to 1 were calculated. The simulation results in Table. 2 demonstrates that IIRWR achieves the best prediction performance when α = 0.6. Similarly, with r varying from 0.1 to 0.9. IIRWR achieve the best prediction performance when r = 0.4 (Table. 3). 
C. CASE STUDIES
Cancer and leukemia have threatened human beings for hundreds of years [35] , [36] . In order to further confirms the practical prediction performance of our IIRWR model, cervical cancer and leukemia were selected as case studies. while simulation, only those leukemia-related lncRNAs and cervical cancer-related lncRNAs which have not been included in the data set of 1695 known lncRNA-disease associations would be considered as validation candidates. And moreover, all predicted lncRNAs associated with leukemia and cervical cancer would be ranked according to their scores respectively. Top 10 disease-related lncRNAs predicted by the IIRWR were confirmed by experiments and articles downloaded from NCBI, and the corresponding evidence was listed in Table. 4 and Table. 5 .
A large number of evidences proves that lncRNA plays a key role in the development of cervical cancer [37] , [38] . As exhibited in Table. 4, when implementing IIRWR to predict cervical cancer-related lncRNAs, there are 8 out of the top 10 predicted candidate lncRNAs having been confirmed by biomedical literature. Rankings of the other two lncRNAs without being confirmed were 8th and 10th, respectively. Similarly, abnormalities of some lncRNAs have been reported closely related to the development of leukemia [39] , [40] . As displayed in Table. 5, 10 out of the top 10 predicted candidate lncRNAs having been confirmed by biomedical literature.
In summary, IIRWR achieves satisfactory and reliable prediction performance in prediction of potential lncRNAdisease associations. 
IV. DISCUSSIONS
Accumulating evidence manifested that lncRNAs play critical roles in various biological processes and relate to the pathological change of human diseases. However, verification of lncRNA-disease associations through bio-experiments is costly and time-consuming. Therefore, it is necessary and feasible by using an effective computational model to infer potential lncRNA-disease associations. In this study, a novel computational model called IIRWR was constructed based on random walk with internal tendency. In order to assess the prediction performance of IIRWR, various experiments have been carried out, simulation results show that IIRWR achieves reliable AUCs of 0.8080, 0.8363 and 0.8745 under the framework of 5-fold CV, 10-fold CV and LOOCV, respectively. Comparing with traditional state-of-the-art computational models, IIRWR outperforms more as well. In addition, in case studies, experimental results further verify that 8 out of the top 10 predicted lncRNAs and 10 out of top 10 predicted lncRNAs are associated with cervical cancer and leukemia separately, which strongly supports that IIRWR greatly improves the recognition of potential lncRNA-disease associations.
Even so, the current version of IIRWR has limitations. For example, only 1695 known lncRNA-disease associations have been adopted by IIRWR, the prediction accuracy of IIRWR will improve higher if more known lncRNA-disease associations are added. Additionally, when applied IIRWR in the situation that a disease has no association with any lncRNA, we tried to change the initial probability vector to the weight probability vector of lncRNAs related to the clique of the specific disease, however, the effect is not very satisfactory. Certainly, all problems in the current version of IIRWR will be the focuses of our following researches.
